drugset / Trial / NCT04350125

PRP for the Treatment of Erectile Dysfunction (ED)

NCT04350125

Phase 1 Completed 4 enrolled Mayo Clinic
NaSequentialOpen-labelTreatment

Summary

Researchers are trying to determine the safety and efficacy of Platelet Rich Plasma (PRP) in the treatment of Erectile Dysfunction (ED).

Timeline

Start
2022-03-04
Primary completion
2023-10-23
Completion
2023-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 4 ml Other
Subject Platelet Rich Plasma Other / unclassified 5 ml Other

Indications